# US 2003/0224994 A1 · Storage stable liquid sealer protein complex

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2003/0224994 A1
- Document ID: US20030224994A1
- Status: Published application
- Kind: A1
- Application number: 10/407,699
- Filed: 2003-04-04
- Published: 2003-12-04
- Earliest claimed: 2002-04-05
- Inventors: Colin John Newton; Thomas Seelich
- Web page: https://patentgrep.com/patent/US20030224994A1

## CPC

- A61L 24/106: {Fibrin; Fibrinogen}
- A61K 38/363: {Fibrinogen}
- A61L 24/001: {Use of materials characterised by their function or physical properties}
- A61L: METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES (preservation of bodies or disinfecting characterised by the agents employed A01N; preserving, e.g. sterilising, food or foodstuffs A23; preparations for medical, dental or toiletry purposes A61K)
- A61K: PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES (devices or methods specially adapted for bringing pharmaceutical products into particular physical or administering forms A61J3/00; chemical aspects of, or use of materials for deodorisation of air, for disinfection or sterilisation, or for bandages, dressings, absorbent pads or surgical articles A61L; soap compositions C11D)

## Abstract

The present invention provides storage stable liquid sealer protein complexes containing fibrinogen that are convenient to store and transport, that are stable over several months, and that do not have to be discarded if an intended surgical procedure is not carried out. The complexes of the invention comprise fibrinogen, an anti-proteolytic agent, an anti-gelling agent, and a physiologically acceptable carrier.

## Claims

### Claim 1

A composition of a storage stable liquid sealer protein, the composition comprising: fibrinogen; an anti-proteolytic agent; an anti-gelling agent; an antioxidant agent; and a physiologically acceptable carrier.

### Claim 2 (depends on 1)

The composition of claim 1, wherein the sealer protein has a reduced level of endogenous plasminogen.

### Claim 3 (depends on 1)

The composition of claim 1, comprising about 60-110 mg/ml fibrinogen.

### Claim 4 (depends on 1)

The composition of claim 1, wherein the anti-proteolytic agent is alpha 2 antiplasmin.

### Claim 5 (depends on 4)

The composition of claim 4, wherein the alpha 2 antiplasmin is present at a concentration of about 5-10 μM.

### Claim 6 (depends on 1)

The composition of claim 1, wherein the anti-proteolytic agent is a member selected from the group consisting of alpha 2 antiplasmin, antithrombin III plus heparin, and alpha 1 protease inhibitor, wherein the composition further comprises aprotinin.

### Claim 7 (depends on 6)

The composition of claim 6, wherein the anti-proteolytic agent is alpha 1 protease inhibitor at a concentration of about 20-50 μM and aprotinin is present at a concentration of about 40-120 μM.

### Claim 8 (depends on 6)

The composition of claim 6, wherein the anti-proteolytic agent is alpha 2 antiplasmin at a concentration of about 5-10 μM and aprotinin is present at a concentration of about 40-120 μM.

### Claim 9 (depends on 6)

The composition of claim 6, wherein the anti-proteolytic agent is antithrombin III at a concentration of about 20-50 μM plus heparin at a concentration of about 10-25 μM, and aprotinin is present at a concentration of about 40-120 μM.

### Claim 10 (depends on 1)

The composition of claim 1, wherein the anti-gelling agent is a member selected from the group consisting of: arginine, histidine, and urea.

### Claim 11 (depends on 1)

The composition of claim 1, wherein the anti-gelling agent is arginine.

### Claim 12 (depends on 11)

The composition of claim 11, wherein the arginine is present in a concentration of about 20 mM to about 50 mM, neutralized to pH 7.3 with citric acid.

### Claim 13 (depends on 11)

The composition of claim 11, wherein the arginine is present in a concentration of about 45 mM to about 50 mM, neutralized to pH 7.3 with citric acid.

### Claim 14 (depends on 1)

The composition of claim 1, wherein the antioxidant agent is glutathione or cysteine.

### Claim 15 (depends on 1)

The composition of claim 1, wherein the antioxidant agent is glutathione.

### Claim 16 (depends on 15)

The composition of claim 15, wherein the glutathione is present at a concentration of about 5 mM.

### Claim 17 (depends on 1)

The composition of claim 1, wherein the composition has been depleted of oxygen by degassing and nitrogen purging.

### Claim 18

A composition of a storage stable liquid sealer protein complex, the composition comprising: fibrinogen at a concentration of about 60-110 mg/ml; about 45-50 mM arginine, neutralized to pH 7.3 with citric acid; about 5 mM glutathione; about 5-10 μM alpha 2 antiplasmin; at least 3 U of Factor XIII per 100 mg of sealer protein; and a physiologically acceptable carrier.

### Claim 19

A composition of a storage stable liquid sealer protein complex, the composition comprising: fibrinogen at a concentration of about 60-110 mg/ml; about 45-50 mM arginine, neutralized to pH 7.3 with citric acid; about 5 mM glutathione; about 5-10 μM alpha 2 antiplasmin; about 45-70 μM aprotinin; at least 3 U of Factor XIII per 100 mg of sealer protein; and a physiologically acceptable carrier.

### Claim 20

A composition of a storage stable liquid sealer protein complex, the composition comprising: fibrinogen at a concentration of about 60-110 mg/ml; about 45-50 mM arginine, neutralized to pH 7.3 with citric acid; about 5 mM glutathione; about 20-30 μM alpha 1 protease inhibitor; about 45-70 μM aprotinin; at least 3 U of Factor XIII per 100 mg of sealer protein; and a physiologically acceptable carrier.

### Claim 21

A composition of a storage stable liquid sealer protein complex, the composition comprising: fibrinogen at a concentration of about 60-110 mg/ml; about 45-50 mM arginine, neutralized to pH 7.3 with citric acid; about 5 mM glutathione; about 20-30 μM antithrombin III; about 10-15 μM heparin; about 45-70 μM aprotinin; at least 3 U of Factor XIII per 100 mg of sealer protein; and a physiologically acceptable carrier.

### Claim 22

A method of making a storage stable liquid fibrinogen composition, said method comprising the step of: reconstituting protein comprising fibrinogen in an aqueous solution comprising an anti-proteolytic agent, an anti-gelling agent, an antioxidant, and a physiologically acceptable carrier.

### Claim 23 (depends on 22)

The method of claim 22, further comprising the step of degassing the solution and N2 purging.

### Claim 24 (depends on 22)

The method of claim 22, further comprising the step of inactivating virus in the solution by treating said composition with UV light.

### Claim 25 (depends on 22)

The method of claim 22, further comprising the step of adding Factor XIII to the composition.
